Heart failure & cardiomyopathies

Conduction System vs Biventricular Pacing in Heart Failure: The PhysioSync-HF Randomized Clinical Trial

JAMA CardiolPublished Randomised controlled trial

Primary resultResult — go to the resultOdds ratio 2.36 95% CI 1.37–4.06

Authors' conclusion

In patients with HFrEF and LBBB, CSP was inferior to BiVP for a composite of death, HF hospitalizations, urgent HF visits, and change in LVEF at 12 months.

Study context

Population
Adults with symptomatic heart failure with reduced ejection fraction (HFrEF) (NYHA II–III), left ventricular ejection fraction (LVEF) ≤35% and left bundle-branch block (LBBB) (QRS ≥130 ms)
Participants
173 adults
Comparison
Conduction system pacing (CSP) vs biventricular pacing (BiVP)
Primary endpoint
Hierarchical composite of:
  1. Death
  2. Heart failure (HF) hospitalizations
  3. Urgent HF visits
  4. Change in LVEF
(non-inferiority margin OR 1.2)
Follow-up
12 months
Methodological detailsmulticentre, non-inferiority, investigator-initiated, 14 hospitals in Brazil
  • Multicentre
  • Non-inferiority
  • Investigator-initiated
  • 14 hospitals in Brazil

Primary result

As reported in the abstract

Odds ratio

2.36

95% CI 1.37–4.06

P = 0.002

CSP vs BiVP
OR 2.36 (95% CI 1.37–4.06); P = 0.002

Further findings

OutcomeHR (95% CI)
Time-to-event composite of death, HF hospitalizations or urgent HF visits2.35 (0.99–5.61)

Mean

OutcomeCSPBiVPMean difference (95% CI)
LVEF35% (SD 12%)39% (SD 12%)3.8% (0.3%–7.3%)
OutcomeDifference (95% CI)
Total direct medical cost (procedure and HF care) · 12 monthsLower with CSP$7090 ($5779-$8648)

QRS duration, KCCQ Overall Summary Score, NYHA class, natriuretic peptides

Comparable improvements from baseline in both groups

Original publication

Conduction System vs Biventricular Pacing in Heart Failure: The PhysioSync-HF Randomized Clinical Trial. JAMA Cardiol. Published 1 April 2026. doi:10.1001/jamacardio.2026.0101

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.